Medical Weight Loss Programme

This programme provides access to a comprehensive medical assessment and personalised weight management pathway. It includes:

• A virtual consultation with one of our independent, HPCSA-registered medical practitioners in the CeleRevive platform network.
• A detailed review of your medical history, current health goals, and any relevant bloodwork.
• Discussion of evidence-based weight management options.
• A tailored treatment plan designed by the medical practitioner, if clinically appropriate. This may include prescription options such as subcutaneous injection pens, oral capsules, or other supportive therapies.

To access any prescription weight loss products, we require a consultation with one of our independent medical professionals. This ensures that you receive expert guidance tailored to your health profile and goals, and helps you make the most appropriate choice.

How the Process Works: Once you have received your script from the consulting doctor, CeleRevive will send you an invoice for the relevant product/s. Once payment has been received, your products will be shipped directly to your doorstep.

Medical Requirements: Recent blood test results (typically within the last 3 months) may be required for certain treatments. You may provide your own results or request assistance from one of our independent practitioners during your consultation.

Note: All products available through the CeleRevive platform are of high purity and are sourced from GMP-compliant manufacturing facilities. All injectables are >98-99% purity. Products are imported and distributed by fully licensed wholesale pharmacies, compounded and dispensed by independent, licensed compounding pharmacies, and supplied only upon prescription by an independent, licensed medical practitioner.

Regulatory Status: Weight management treatments such as compounded semaglutide and tirzepatide are prepared on an individual, patient-specific basis where clinically appropriate. Some formulations are registered medicines, while others (including certain combinations or experimental peptides) are supplied as compounded or off-label options under South African regulatory frameworks. The consulting medical practitioner will disclose the exact regulatory status of any recommended or prescribed products. All prescriptions are issued at the sole discretion of the consulting practitioner.